Evidence map›Paper›PMID 15872281›Full record

ArticleJournal of clinical microbiology2005

Prevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12.

Jungmin Kim, Yu-Mi Lim

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. A brief insight intoFrontiers in antibiotics · 2023
    Review
  3. Article
  4. Antimicrobial agents and chemotherapy · 2018
    Article
  5. Article
  6. Clinical medicine insights. Case reports · 2016
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frequent detection of plasmid-mediated quinolone resistance (qnr) genes in multidrug-resistant Enterobacteriaceae blood isolates, Hong Kong.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  12. Review
  13. CTX-M-14 β-lactamase-producing Citrobacter freundii isolated in Venezuela.Annals of clinical microbiology and antimicrobials · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2007
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jungmin KimDepartment of Microbiology, Kyungpook University School of Medicine, Daegu, Korea. minkim@dankook.ac.kr
Yu-Mi Lim

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The resistance mechanism of extended-spectrum cephalosporins in clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens was studied. Of 152 isolates, 45 isolates (29.6%) were derepressed AmpC mutants and 39 isolates (25.7%) produced extended-spectrum beta-lactamase (ESBLs). The most prevalent ESBLs were CTX-M enzymes, followed by TEM-52 and SHV-12.

Indexed as

Bacterial ProteinsBase Sequencebeta-LactamasesCephalosporinsCitrobacterDNA PrimersEnterobacterHumansKoreaMicrobial Sensitivity TestsSerratia marcescensAmpC beta-lactamasesBacterial Proteinsbeta-LactamasesCephalosporinsDNA Primers

Identifiers

PMID15872281
PMCPMC1153749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.